Exact Mass: 429.1036

Besifloxacin HCl

C19H22Cl2FN3O3 (429.1022)

D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

Sulfamethoxazole N1-glucuronide

C16H19N3O9S (429.0842)

Sulfamethoxazole N1-glucuronide is a metabolite of Sulfamethoxazole. Sulfamethoxazole n1-glucuronide belongs to the family of Phenols and Derivatives. These are compounds containing a phenol moiety, which is a benzene bearing an hydroxyl group.

Altropane

C18H21FINO2 (429.0601)

Azalanstat

C22H24ClN3O2S (429.1278)

Zofenopril

C22H23NO4S2 (429.1068)

trans-zeatin riboside monophosphate

C15H20N5O8P (429.1049)

Cis-zeatin riboside monophosphate is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Cis-zeatin riboside monophosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Cis-zeatin riboside monophosphate can be found in a number of food items such as lichee, swiss chard, catjang pea, and teff, which makes cis-zeatin riboside monophosphate a potential biomarker for the consumption of these food products.

LYCOGARUBIN B

C24H19N3O5 (429.1325)

Cottoquinazoline A

C23H19N5O4 (429.1437)

ZINC12369505

C17H14F3N3O5S (429.0606)

Q63396586

C17H15N7O5S (429.0855)

TCMDC-134227

C25H23N3O2S (429.1511)

Antibiotic FD 839

C22H23NO8 (429.1424)

beta-D-glucopyranuronic acid 3-(2-amino-4-oxo-3,4-dihydro-pteridin-6-yl)-2,3-dihydroxy-propyl ester|Neopterin-3-beta-D-glucuronid

C15H19N5O10 (429.1132)

14N-Ac-9-[(2-Amino-2-carboxyethyl)thio]-10-hydroxy-3,5,7-tetradecatrienedioic acid

C19H27NO8S (429.1457)

Serranticin

C21H23N3O7 (429.1536)

(5R)-3-methyl-2(5H)furanone-(5->6)-(6R)-5,6-dihydrosanguinarine|maclekarpine C

C25H19NO6 (429.1212)

N-Methyloxohydrasteine

C22H23NO8 (429.1424)

SCHEMBL7153244

C19H19N5O7 (429.1284)

DTXSID20825858

C22H23NO8 (429.1424)

oxocoryrutine

C22H23NO8 (429.1424)

acuminaminoside

C22H23NO8 (429.1424)

C22H23NO8

C22H23NO8 (429.1424)

Erlotinib HCL

C22H24ClN3O4 (429.1455)

Pefloxacin mesylate

C18H24FN3O6S (429.137)

L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants > L03AA - Colony stimulating factors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic

Besifloxacin HCl (Besivance)

C19H22Cl2FN3O3 (429.1022)

SMZ-PtO

C17H15N7O5S (429.0855)

CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b); ALGAE_TP_ID 3103 ALGAE_TP_ID 3103; CONFIDENCE Probable structure via diagnostic evidence, tentative identification (Level 2b)

MMV024035

C25H23N3O2S (429.1511)

Dereplicator+ Identification - Serratiochelin

C21H23N3O7 (429.1536)

Cys Gly His Asn

C15H23N7O6S (429.143)

Cys Gly Asn His

C15H23N7O6S (429.143)

Cys His Gly Asn

C15H23N7O6S (429.143)

Cys His Asn Gly

C15H23N7O6S (429.143)

Cys Asn Gly His

C15H23N7O6S (429.143)

Cys Asn His Gly

C15H23N7O6S (429.143)

Gly Cys His Asn

C15H23N7O6S (429.143)

Gly Cys Asn His

C15H23N7O6S (429.143)

Gly His Cys Asn

C15H23N7O6S (429.143)

Gly His Asn Cys

C15H23N7O6S (429.143)

Gly Asn Cys His

C15H23N7O6S (429.143)

Gly Asn His Cys

C15H23N7O6S (429.143)

His Cys Gly Asn

C15H23N7O6S (429.143)

His Cys Asn Gly

C15H23N7O6S (429.143)

His Gly Cys Asn

C15H23N7O6S (429.143)

His Gly Asn Cys

C15H23N7O6S (429.143)

His Asn Cys Gly

C15H23N7O6S (429.143)

His Asn Gly Cys

C15H23N7O6S (429.143)

Asn Cys Gly His

C15H23N7O6S (429.143)

Asn Cys His Gly

C15H23N7O6S (429.143)

Asn Gly Cys His

C15H23N7O6S (429.143)

Asn Gly His Cys

C15H23N7O6S (429.143)

Asn His Cys Gly

C15H23N7O6S (429.143)

Asn His Gly Cys

C15H23N7O6S (429.143)

Sulfamethoxazole glucuronide

C16H19N3O9S (429.0842)

Sulfamethoxazole N glucuronide

C16H19N3O9S (429.0842)

14-carboxy-15,16,17,18,19,20-hexanor-N-acetyl-leukotriene E4

C19H27NO8S (429.1457)

Amicycline

C21H23N3O7 (429.1536)

C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

Suncillin

C16H19N3O7S2 (429.0664)

7-(Benzyloxy)-4-(4-Fluoro-2-Methyl-1h-Indol-5-Yloxy)-6-Methoxyquinazoline

C25H20FN3O3 (429.1489)

4-({[(2S,4S)-2-[2-(4-Chlorophenyl)ethyl]-2-(1H-imidazol-1-ylmethy l)-1,3-dioxolan-4-yl]methyl}sulfanyl)aniline

C22H24ClN3O2S (429.1278)

2-O-Succinyl-cAMP

C14H16N5O9P (429.0686)

2'-O-Succinyl-cAMP is a cAMP analog that can be covalently coupled to acetylcholinesterase. 2'-O-Succinyl-cAMP conjugate has been used as tracers in a classical heterogeneous competitive enzyme immunoassay allowing the determination of cAMP[1][2].

alx 5407 hydrochloride

C24H25ClFNO3 (429.1507)

2-[4-[(2-chloro-4-nitrophenyl)azo]-N-(2-cyanoethyl)-3-methylanilino]ethyl acetate

C20H20ClN5O4 (429.1204)

(2-DIMETHYLAMINO-4-NITROPHENYL) PHOSPHORIC ACID DIAMMONIUM SALT MONOHYDRATE

C8H25N5O11P2 (429.1026)

Salazodine

C18H15N5O6S (429.0743)

Zofenopril

C22H23NO4S2 (429.1068)

C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

4-nitrooxybutyl 2-(5-hydroxy-4-oxo-2-phenylchromen-7-yl)oxyacetate

C21H19NO9 (429.106)

N-(2-Benzoyl-4-nitrophenyl)-1,3-dihydro-1,3-dioxo-2H-isoindole-2-acetamide

C23H15N3O6 (429.0961)

tert-Butyl 2-(4-((2-chloro-4-fluorobenzyl)oxy)phenylsulfonamido)acetate

C19H21ClFNO5S (429.0813)

Erlotinib hydrochloride

C22H24ClN3O4 (429.1455)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

acridinyl anisidide

C21H20ClN3O3S (429.0914)

Bis(4-tert-butylphenyl)iodonium chloride

C20H27ClI+ (429.0846)

[4-(2,4-difluorophenyl)-2-(phenylcarbamoyl)phenyl] benzoate

C26H17F2NO3 (429.1176)

4-Chloromethyl-n-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide

C24H20ClN5O (429.1356)

7-Didemethyl Minocycline

C21H23N3O7 (429.1536)

Anthrimide

C28H15NO4 (429.1001)

3-[N-(2-hydroxyethyl)-4-[(6-methylsulfonyl-1,3-benzothiazol-2-yl)diazenyl]anilino]propanenitrile

C19H19N5O3S2 (429.0929)

ethyl 1,4-dihydro-7-[(S,S)-3-methoxy-4-methylamino-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylate

C20H23N5O4S (429.1471)

resorcin blue, pure

C24H15NO7 (429.0848)

[(1H-Benzotriazol-1-yl)methyl]triphenylphosphonium Chloride

C25H21ClN3P (429.1162)

Phosphonic acid, P,P-(dichloromethylene)bis-, compd. with N,N-dibutyl-1-butanamine (1:1)

C13H31Cl2NO6P2 (429.1004)

(alphaZ)-5-Amino-alpha-[(triphenylmethoxy)imino]-1,2,4-thiadiazole-3-acetic acid ion(1-)

C23H17N4O3S (429.1021)

2-[[(3aR,4S,6R,6aS)-6-(7-chloro-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy]ethanol

C17H24ClN5O4S (429.1237)

(Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid

C24H19N3O3S (429.1147)

3-(4-chlorophenyl)-9-(4-phenylphenyl)carbazole

C30H20ClN (429.1284)

2-[3-(1H-imidazol-5-yl)propyl]-1-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine,trihydrochloride

C14H26Cl3N7S (429.1036)

2-(Fmoc-amino)-2-(1,1-dioxo-4-tetrahydrothiopyranyl)acetic Acid

C22H23NO6S (429.1246)

Funapide

C22H14F3NO5 (429.0824)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

Altropane

C18H21FINO2 (429.0601)

Altropane I-123

C18H21FINO2 (429.0601)

Rac-N-Methyllaudanosolinium Trifluoroacetate

C20H22F3NO6 (429.1399)

A natural product found in Gnetum montanum.

Tetraphenylstibonium

C24H20Sb+ (429.0603)

N-(4-fluoro-3-(6-pyridin-2-yl-(1,2,4)triazolo(1,5-a)pyrimidin-2-yl)phenyl)-2,4-dimethyl-1,3-oxazole-5-carboxamide

C22H16FN7O2 (429.1349)

4-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-N-(4,6-dimethyl-2-pyridinyl)-1-piperazinecarbothioamide

C18H19ClF3N5S (429.1002)

2-Furanyl-[4-[(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-thiophen-2-ylmethyl]-1-piperazinyl]methanone

C19H19N5O3S2 (429.0929)

Serratiochelin

C21H23N3O7 (429.1536)

[4-(4-Acetylamino-phenyl)-3,5-dioxo-4-aza-tricyclo[5.2.2.0 2,6]undec-1-ylcarbamoyloxy]-acetic acid

C21H23N3O7 (429.1536)

(2-Mercaptomethyl-4-phenyl-butyrylimino)-(5-tetrazol-1-ylmethyl-thiophen-2-yl)-acetic acid

C19H19N5O3S2 (429.0929)

(2S,5R,6R)-6-({(6S)-6-[(ammonioacetyl)amino]-6-carboxylatohexanoyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C17H25N4O7S- (429.1444)

Ipratropium bromide hydrate

C20H32BrNO4 (429.1515)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents

N-phenyl-5-(7-piperidin-4-yloxyisoquinolin-6-yl)thiophene-2-carboxamide

C25H23N3O2S (429.1511)

9-Ribosyl-trans-zeatin 5-phosphate(2-)

C15H20N5O8P-2 (429.1049)

Mannosylglucosylglycerate

C15H25O14- (429.1244)

N-acetyl-L-aspartyl-L-glutamyl-L-glutamate

C16H19N3O11-4 (429.102)

CMP-(2-aminoethyl)phosphonate

C11H19N4O10P2- (429.0576)

2-O-[alpha-D-Glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-D-glycerate

C15H25O14- (429.1244)

cZRMP

C15H20N5O8P-2 (429.1049)

(2-Amino-3-oxopropyl) [3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate

C14H28N3O8PS (429.1335)

(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(2,5-dihydroxy-3-methylphenyl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

C17H23N3O8S (429.1206)

methyl 3-(4-fluorophenyl)-8-[(E)-3-iodoprop-2-enyl]-8-azabicyclo[3.2.1]octane-2-carboxylate

C18H21FINO2 (429.0601)

4-[({2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolan-4-yl}methyl)sulfanyl]aniline

C22H24ClN3O2S (429.1278)

[3,4-dihydroxy-5-[6-[[(E)-4-hydroxy-3-methylbut-2-enyl]amino]purin-9-yl]oxolan-2-yl]methyl phosphate

C15H20N5O8P-2 (429.1049)

Tarceva

C22H24ClN3O4 (429.1455)

D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

tarocin A2

C22H18F3N3O3 (429.13)

3-(2-Benzo[1,3]dioxol-5-yl-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl)-benzonitrile

C24H15NO7 (429.0848)

[5-[(4-Methoxyphenyl)methylamino]-3-phenyl-1,2,4-triazol-1-yl]-(4-nitrophenyl)methanone

C23H19N5O4 (429.1437)

3-[2-[4-(2-Chloro-4-nitrophenyl)-1-piperazinyl]ethoxy]-4-phenyl-1,2,5-oxadiazole

C20H20ClN5O4 (429.1204)

1-Ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid methanesulfonate

C18H24FN3O6S (429.137)

1-[2-[[(2,4-Dichloroanilino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

C19H25Cl2N3O4 (429.1222)

N-[3-(4-morpholinylsulfonyl)phenyl]-4-(2-oxo-1-pyrrolidinyl)benzamide

C21H23N3O5S (429.1358)

{[(1r,7r)-4-(4-Acetamidophenyl)-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-1-yl]carbamoyloxy}acetic acid

C21H23N3O7 (429.1536)

N-(3-carbamoyl-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-3-(2-chlorophenyl)-5-methyl-4-isoxazolecarboxamide

C21H20ClN3O3S (429.0914)

methyl 3-[[2-[1,3-benzodioxol-5-yl(ethyl)amino]acetyl]amino]-5-chloro-1H-indole-2-carboxylate

C21H20ClN3O5 (429.1091)

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[[1-(3,4-dimethoxyphenyl)-5-tetrazolyl]thio]acetamide

C19H19N5O5S (429.1107)

4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide

C21H20ClN3O3S (429.0914)

2-chloro-N-[3-(5-methyl-1,3-benzoxazol-2-yl)phenyl]-5-(1,2,4-triazol-4-yl)benzamide

C23H16ClN5O2 (429.0992)

N-(phenylmethyl)-2-[[4-(trifluoromethyl)-5,6-dihydrobenzo[h]quinazolin-2-yl]thio]acetamide

C22H18F3N3OS (429.1123)

3,4,5-trimethoxy-N-[[[(1S,2S)-2-phenylcyclopropanecarbonyl]amino]carbamothioyl]benzamide

C21H23N3O5S (429.1358)

3-(2-bromophenyl)-4-[(E)-[4-(diethylamino)phenyl]methylideneamino]-1H-1,2,4-triazole-5-thione

C19H20BrN5S (429.0623)

tert-butyl (2S)-2-[5-[(2,4-dichlorophenyl)methylsulfanyl]-1,3,4-oxadiazol-2-yl]pyrrolidine-1-carboxylate

C18H21Cl2N3O3S (429.0681)

2-(2-Bromophenyl)-3-[3-(4-morpholinyl)propyl]-1,2-dihydroquinazolin-4-one

C21H24BrN3O2 (429.1052)

2-[2-oxo-6-(1-pyrrolidinylsulfonyl)-1,3-benzoxazol-3-yl]-N-(1-phenylethyl)acetamide

C21H23N3O5S (429.1358)

N-[2,5-diethoxy-4-[[(2-furanylmethylamino)-sulfanylidenemethyl]amino]phenyl]-2-furancarboxamide

C21H23N3O5S (429.1358)

2-chloro-N-(2-{(2E)-2-[(5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)methylene]hydrazino}-2-oxoethyl)benzamide

C20H17Cl2N5O2 (429.0759)

D-xylotrionate

C15H25O14- (429.1244)

N-(18-Phenyl-11-oxa-13,15-diazatetracyclo[8.8.0.02,7.012,17]octadeca-1(10),2,4,6,8,12,14,16-octaen-16-yl)benzamide

C28H19N3O2 (429.1477)

3-O-acetyl-8-O-demethylmaritidine Trifluoroacetic acid

C20H22F3NO6 (429.1399)

A natural product found in Crinum asiaticum var. sinicum.

(2R)-2-O-[alpha-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl]-glycerate

C15H25O14- (429.1244)

(4-(2,5-Di(furan-2-yl)pyrazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl)(furan-3-yl)methanone

C23H19N5O4 (429.1437)

Bispyribac anion

C19H17N4O8- (429.1046)

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

3-[4-[(1R,5S)-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1511)

4-[4-[(1S,5R)-3-(phenylmethyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1511)

4-[4-[(1R,5S)-3-(2-methylphenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzonitrile

C25H23N3O2S (429.1511)

methyl 2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetate

C19H27NO8S (429.1457)

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

methyl 2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetate

C19H27NO8S (429.1457)

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

(6R,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-(1-oxo-2-pyridin-4-ylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C20H20BrN3O3 (429.0688)

2-[(2R,4aR,12aR)-5-methyl-8-[[(5-methyl-3-isoxazolyl)-oxomethyl]amino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid

C21H23N3O7 (429.1536)

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(2-methoxyphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]acetic acid methyl ester

C19H27NO8S (429.1457)

(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-(1-oxo-2-pyridin-4-ylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C20H20BrN3O3 (429.0688)

(6R,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-4-(1-oxo-2-pyridin-4-ylethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C20H20BrN3O3 (429.0688)

3-Dehydroisovitexin

C21H17O10- (429.0822)

2-methyl-5-oxo-7-thiophen-2-yl-4-(3-thiophenyl)-4,6,7,8-tetrahydro-3H-quinoline-3-carboxylic acid 2-methoxyethyl ester

C22H23NO4S2 (429.1068)

methyl 2-[(6-O-alpha-D-mannopyranosyl-alpha-D-mannopyranosyl)thio]ethanimidate

C15H27NO11S (429.1305)

2-Chloro-N-[3-[(Z)-2-cyano-3-oxo-3-(2-phenylethylamino)prop-1-enyl]phenyl]benzamide

C25H20ClN3O2 (429.1244)

5-[[4-[(E)-2-(1H-benzimidazol-2-yl)-2-cyanoethenyl]-2-ethoxyphenoxy]methyl]furan-2-carboxylic acid

C24H19N3O5 (429.1325)

2-[(E)-(2-oxo-1H-indol-3-ylidene)amino]-N-(2-phenylethyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide

C25H23N3O2S (429.1511)

N-[4-[[5-[3-(2-aminoethyl)-1H-indol-5-yl]-1,2,4-oxadiazol-3-yl]methyl]phenyl]methanesulfonamide;hydrate

C20H23N5O4S (429.1471)

9-Ribosyl-trans-zeatin 5-phosphate(2-)

C15H20N5O8P (429.1049)

A organophosphate oxoanion that is that is AMP(2-) substituted at position N-6 by a (2E)-4-hydroxy-3-methylbut-2-en-1-yl group; major species at pH 7.3.

Sulfamethoxazole N1-glucuronide

C16H19N3O9S (429.0842)

2-O-[alpha-D-mannosyl-(1->2)-alpha-D-glucosyl]-D-glycerate

C15H25O14 (429.1244)

A carbohydrate acid derivative anion that is the conjugate base of 2-O-[alpha-D-mannosyl-(1->2)-alpha-D-glucosyl]-D-glyceric acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

LPS 8:2;O3

C14H24NO12P (429.1036)

LPS 9:1;O2

C15H28NO11P (429.14)

Befiradol (hydrochloride)

C20H23Cl2F2N3O (429.1186)

Befiradol hydrochloride (NLX-112 hydrochloride) is a selective 5-HT1A receptor agonist.

Ipratropium (bromide hydrate)

C20H32BrNO4 (429.1515)

Ipratropium bromide (Sch 1000) hydrate is a muscarinic receptor antagonist, with IC50s of 2.9 nM, 2 nM, and 1.7 nM for M1, M2, and M3 receptors, respectively. Ipratropium bromide hydrate relaxes smooth muscle, can be used in the research for COPD (chronic obstructive pulmonary disease) and asthma[1][2][3][4][5].

UBP316

C20H19N3O6S (429.0995)

UBP316 (ACET) is a highly potent and selective kainate receptor GluK1 (GluR5) antagonist, with a Kb value of 1.4 nM. UBP316 is effective at blocking the depression of both field excitatory postsynaptic potentials (fEPSPs) and monosynaptically-evoked GABAergic transmission induced by ATPA, a GluK1 selective agonist[1].

(5r)-3-methyl-5-[(23s)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl]-5h-furan-2-one

C25H19NO6 (429.1212)

1-acetyl-5-hydroxy-6-[(2r,4r,5s,6r)-5-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]-3-methylnaphtho[2,3-c]thiophene-4,9-dione

C22H23NO6S (429.1246)

(3s,12r,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

6-[2,3-dihydroxy-3-(4-hydroxy-2-imino-1h-pteridin-6-yl)propoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H19N5O10 (429.1132)

1-(2-amino-1-benzofuran-3-yl)-2-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethanone

C22H23NO8 (429.1424)

3-nitropropyl allolactoside

C15H27NO13 (429.1482)

{"Ingredient_id": "HBIN008981","Ingredient_name": "3-nitropropyl allolactoside","Alias": "NA","Ingredient_formula": "C15H27NO13","Ingredient_Smile": "NA","Ingredient_weight": "429.377","OB_score": "NA","CAS_id": "117845-08-O","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8027","PubChem_id": "NA","DrugBank_id": "NA"}

acuminaminoside

C22H23NO8 (429.1424)

{"Ingredient_id": "HBIN014647","Ingredient_name": "acuminaminoside","Alias": "NA","Ingredient_formula": "C22H23NO8","Ingredient_Smile": "C1=CC=C(C(=C1)CC(=O)C2=C(OC3=CC=CC=C32)N)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "429.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "590","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21577089","DrugBank_id": "NA"}

(5s,8r,9s)-8-benzoyl-2-[(1z,3z)-1,4-dihydroxyhexa-1,3-dien-1-yl]-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C22H23NO8 (429.1424)

8-benzoyl-2-(1,4-dihydroxyhexa-1,3-dien-1-yl)-6,9-dihydroxy-8-methoxy-3-methyl-1-oxa-7-azaspiro[4.4]nona-2,6-dien-4-one

C22H23NO8 (429.1424)

(1s,3s,12r,14r,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

methyl 5-[(1e)-2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-1,2-dihydroxyethenyl]-2h-1,3-benzodioxole-4-carboxylate

C22H23NO8 (429.1424)

2-(3-chlorophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20ClNO3 (429.1132)

2,5-dimethyl 3-(5-hydroxy-1h-indol-3-yl)-4-(1h-indol-3-yl)-1h-pyrrole-2,5-dicarboxylate

C24H19N3O5 (429.1325)

(2s,3s,4s,5r,6r)-6-[(2r,3r)-2,3-dihydroxy-3-(4-hydroxy-2-imino-1h-pteridin-6-yl)propoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H19N5O10 (429.1132)

(1s,3r,12r,14r,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

1-acetyl-5-hydroxy-6-[5-hydroxy-6-methyl-4-(methylamino)oxan-2-yl]-3-methylnaphtho[2,3-c]thiophene-4,9-dione

C22H23NO6S (429.1246)

(1s,3s,12s,14s,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

2-(4-chlorophenyl)-3-[2-(hydroxymethyl)-3-methoxyphenyl]-10-methyl-2-azatricyclo[6.3.1.0⁴,¹²]dodeca-1(11),3,6,8(12),9-pentaen-5-one

C26H20ClNO3 (429.1132)

methyl 5-(2-{6-[2-(dimethylamino)ethyl]-2h-1,3-benzodioxol-5-yl}-1,2-dihydroxyethenyl)-2h-1,3-benzodioxole-4-carboxylate

C22H23NO8 (429.1424)

3-methyl-5-{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl}-5h-furan-2-one

C25H19NO6 (429.1212)

(5r)-3-methyl-5-[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl]-5h-furan-2-one

C25H19NO6 (429.1212)

5-(2-{2-[2-(dimethylamino)ethyl]-4,5-dimethoxyphenyl}-2-oxoacetyl)-2h-1,3-benzodioxole-4-carboxylic acid

C22H23NO8 (429.1424)

(9s,12s,15s)-9-amino-4,10,13-trihydroxy-12-(hydroxymethyl)-2-oxa-11,14-diazatricyclo[15.2.2.1³,⁷]docosa-1(19),3(22),4,6,10,13,17,20-octaene-15-carboxylic acid

C21H23N3O7 (429.1536)

2-hydroxy-n-[(9s)-5,13,19-trimethoxy-6-oxo-15,17-dioxatetracyclo[10.7.0.0²,⁸.0¹⁴,¹⁸]nonadeca-1(19),2,4,7,12,14(18)-hexaen-9-yl]ethanimidic acid

C22H23NO8 (429.1424)

1-(2-amino-1-benzofuran-3-yl)-2-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethanone

C22H23NO8 (429.1424)

(1r,3s,12r,14s,27s)-12,26-dihydroxy-3-methyl-2,5,15,23,25-pentaazaheptacyclo[12.10.2.1²,⁵.0⁶,¹¹.0¹⁵,²⁴.0¹⁷,²².0¹²,²⁷]heptacosa-6,8,10,17,19,21,23,25-octaene-4,16-dione

C23H19N5O4 (429.1437)

(14s)-14-(methoxycarbonyl)-9-methyl-12-oxo-14-phenyl-13-oxa-2,9-diazatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7,11(15),16-hexaene-4-carboximidic acid

C24H19N3O5 (429.1325)